[Malaria in the emergency room. Results of the emergency treatment of 137 patients with symptomatic malaria].
OBJECTIVE
To assess characteristics and outcome of emergency patients with acute malaria.


METHODS
We retrospectively assessed the clinical and laboratory parameters of 137 consecutive patients (87 males, 50 females; median age 37 years, range 17 - 67 years) presenting with acute malaria to our tertiary care center between 1992 and 2002.


RESULTS
Falciparum malaria was diagnosed in 116/137 and tertian malaria in 19/137 patients; a single patient was infected with both parasites while in another case the type of parasite remained unclear. Infections were acquired in Africa (121), Asia , and in the Americas . One traveler visited multiple continents. Only 36 % (50/137) of patients had used malaria chemoprophylaxis. 128/137 patients were treated as in-patients; 22 of these had to be treated on an intensive care unit. According to the criteria of the German Society of Tropical Medicine, 44/137 (32 %; 95 % confidence interval (CI): 25 - 40 %) patients suffered from complicated malaria. The overall mortality rate was 2/137 (1.5 %; 95 % CI: 0,4 - 5.2 %); the mortality rate of complicated malaria tropica was 2/44 (4,5 %; 95 % CI 1,3 - 15 %). Patients with complicated malaria were significantly older than those with uncomplicated malaria. Median length of hospital stay was 4 days in uncomplicated and 9 days in complicated cases. Based on costs of EUR 2500 per case, an attack rate of > 3 % in East African travelers and a cost of EUR 55 for a chemoprophylaxis with mefloquine, chemoprophylaxis is cost-effective.


CONCLUSIONS
In our retrospective analysis, complicated malaria tropica was associated with older age. Although malaria causes considerable morbidity, the overall mortality from severe malaria is low. Reinforcement of chemoprophylaxis especially in travelers to Africa could reduce malaria cases and is cost-effective.
Rabe
C
C
Medizinische Klinik und Poliklinik I, Universitätskliniken Bonn. Rabe@uni-bonn.de
Paar
W D
WD
Knopp
A
A
Münch
J
J
Musch
A
A
Rockstroh
J
J
Martin
S
S
Sauerbruch
T
T
Dumoulin
F L
FL
D000293:Adolescent; D000328:Adult; D000349:Africa; D000367:Age Factors; D000368:Aged; D001208:Asia; D002489:Central America; D018890:Chemoprevention / Q000191:economics; D003362:Cost-Benefit Analysis; D004632:Emergency Medical Services; D005260:Female; D005858:Germany / Q000453:epidemiology; D006801:Humans; D007902:Length of Stay; D008288:Malaria / Q000188:drug therapy / Q000453:epidemiology* / Q000401:mortality / Q000517:prevention & control; D016778:Malaria, Falciparum / Q000188:drug therapy / Q000453:epidemiology* / Q000401:mortality / Q000517:prevention & control; D016780:Malaria, Vivax / Q000188:drug therapy / Q000453:epidemiology* / Q000401:mortality / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D041122:Plasmodium ovale; D012189:Retrospective Studies; D013020:South America; D014195:Travel; D016896:Treatment Outcome